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Objective: Loneliness is a key public health issue for which various interventions have been 
trialled. However, few directly target the core feature of loneliness—lack of belonging. This 
is the focus of GROUPS 4 HEALTH (G4H), a recently developed intervention that targets the 
development and maintenance of social group memberships to support health.  
Method: To investigate the efficacy of this intervention, a randomized controlled trial was 
conducted with participants (N=120) assigned to G4H or treatment-as-usual (TAU) by 
computer software. Assessment of primary (loneliness) and secondary (depression, social 
anxiety, general practitioner visits, multiple group membership) outcomes was conducted at 
baseline and 2-month follow-up using mixed-model repeated-measures analyses.  
Results: G4H produced a greater reduction in loneliness (d = -1.16) and social anxiety (d = -
0.53) than TAU (ds =-0.36, 0.03, respectively). G4H was also associated with fewer general 
practitioner visits at follow-up (d = -0.21) and a stronger sense of belonging to multiple 
groups (d = 0.96) relative to TAU (d = 0.21, d = 0.42, respectively). Depression declined 
significantly in both G4H (d = -0.67) and TAU (d = -0.35), but follow-up analyses showed 
this was greater in G4H among those not receiving adjunct psychopharmacological treatment 
and whose symptoms were milder.  
Conclusions: Findings suggest that G4H can be a useful way to treat loneliness and highlight 
the importance of attending to group memberships when tackling this important social 
challenge.         
 
Key words: Loneliness, social anxiety, social identity, GROUPS 4 HEALTH 
Public Health significance:  This study demonstrates how an intervention derived from 
social identity theorizing can target social isolation and in so doing reduce loneliness and 
symptoms of depression, and social anxiety.   
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Social isolation is experienced by a large number of people, and is particularly 
common in vulnerable populations — for instance, people who are socially disadvantaged 
such as immigrants and minority groups, or those with disability. If isolation leads to a 
subjective sense of loneliness, it can be toxic to health with wide ranging consequences on 
people’s mental health (e.g., Cacioppo, Hughes, Waite, Hawkley, & Thisted, 2006; Hawkley 
& Cacioppo, 2010), physical health, and mortality (e.g., Cacioppo et al., 2002; Holt-Lunstad 
et al., 2010).  These various outcomes therefore make it a priority for intervention. 
Approaches to managing loneliness are diverse, though not all are informed by theory, and 
evidence of their effectiveness is mixed (Mann et al., 2017; Masi, Chen, Hawkley, & 
Cacioppo, 2011). However, a recently developed psychoeducational intervention — GROUPS 
4 HEALTH (G4H) — seeks to address this theory–practice gap by drawing on evidence of the 
role that people’s group-based social identifications play in supporting health (Haslam, 
Jetten, Cruwys, Dingle, & Haslam, 2018), whilst also providing a novel approach to 
managing loneliness. In this paper, we report on a randomized controlled trial (RCT) of G4H 
involving adults presenting with psychological distress in association with loneliness.       
Loneliness interventions    
  Loneliness is essentially unwanted social isolation, and has been characterized as the 
discrepancy between a person’s actual social relationships and those they desire. Its 
prevalence is high and, some authors argue, is growing (e.g., Cacioppo et al., 2015). In a UK 
survey one in ten people reported feeling lonely often, and about 42% reported being 
depressed because they felt alone (Griffin, 2010). Figures from other surveys conducted in 
the United States and Australia indicate that one in three adults over 45 years of age (Wilson 
& Moulton, 2010), and 60% of adults in general (Lifeline, 2016), often reported feeling 
lonely. Loneliness is commonly associated with a range of chronic mental health conditions 
— including depression, psychosis, and social anxiety — and is reported to be more 
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prevalent in some populations (e.g., vulnerable older adults). It is also associated with 
increased risk of mortality and morbidity (see Holt-Lunstad, Smith, & Layton, 2010; Lim, 
Rodebaugh, Zyphur, & Gleeson, 2016). As these data suggest, loneliness is therefore a major 
public health issue that is widely understood to warrant both research attention and practical 
intervention.  
To this end, a range of interventions have been developed to reduce loneliness (see 
Mann et al., 2017; Masi, Chen, Hawkley, & Cacioppo, 2011). These essentially fall into one 
of three categories. The first and most basic approach targets the development and mastery of 
social skills, which are thought to be deficient in people who are lonely (e.g., Twentyman & 
Zimering, 1979). The second approach focuses directly on increasing social contact, 
interaction, and support. Interestingly, a meta-analysis of loneliness interventions found that 
these approaches were less effective than those in a third category, which target cognitive 
biases (Masi et al., 2011). The latter were found to be associated with a moderate effect size 
(d=.598), but were also rather diverse in content, making it difficult to establish the particular 
cognitive processes responsible for improvement.  
Of these approaches, only the third category — those targeting cognitive biases — is 
derived from a coherent body of theory. Informed by principles of cognitive behaviour 
theory, social-cognitive interventions attribute the cause of loneliness to cognitive biases 
(e.g., irrational, self-defeating thoughts) that result from increased vigilance to social threats 
(Cacioppo, Cacioppo, & Boomsma, 2014; Cacioppo & Hawkley, 2009). Were this sufficient 
as a target for intervention, then we might expect greater consistency in their effectiveness. 
Yet, the meta-analysis by Masi and colleagues revealed a wide range in the effect sizes of 
social-cognitive interventions for loneliness; from -4.81 to 0.12 when all study designs are 
considered and -0.97 to -0.32 in the more rigorous randomized group comparison studies. 
This raises the question of whether we can improve these outcomes by targeting another core 
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feature of loneliness: people’s sense of wider connectedness to others in society — to which 
social group-based belonging is integral. This is the focus of a recent body of research that 
applies social identity theorizing to a broad range of health challenges.       
The Social Identity Approach to Health 
Similar to the social-cognitive perspective on loneliness, an understanding that 
humans are social animals is central to social identity theorising (Tajfel & Turner, 1979; 
Turner, Hogg, Oakes, Reicher, & Wetherell, 1987). However, this approach differs in its 
emphasis on the importance of social groups, and on people’s sense of connectedness, 
through social identification, with those groups. This approach recognizes that the self is 
comprised not only of those attributes and traits that are unique to an individual (i.e., a 
person’s personal identity as “I” or “me”; e.g.,  a sense of one’s unique interests or attributes; 
Turner, 1982), but also by the social groups to which he or she belongs (i.e., a sense of social 
identity; e.g., as “us women”, “us Londoners”, or “us cyclists”). Critical here is the idea that 
the group memberships that form part of our social identities have the power to influence the 
way we think, feel and act in different situations. So, for example, membership in groups can 
affect our response to stress and challenge, who we turn to for support, and whether we 
engage (or do not engage) in particular health behaviours (e.g., smoking, exercise). Group 
memberships have this impact in part because they are an important psychological resource 
— providing a framework within which our sense of who we are is constructed. Amongst 
other things, this means that group memberships provide us with a sense of meaning, purpose 
and belonging, the means to enhance self-esteem and perceived control, as well as access to 
social support (see Haslam et al., 2018; Jetten et al., 2012, for reviews).  
The Social Identity Approach to Health (SIAH; Haslam et al., 2018) takes this 
argument a step further to provide an integrated socio-psychological account of the role that 
group memberships play in the development and management of a broad range of health 
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conditions and contexts (Haslam, Jetten, Postmes, & Haslam, 2009). This framework is built 
on two key hypotheses: the social identity hypothesis, which proposes that because social 
identity is the basis for meaningful group life, it is central to good and ill health, and the 
identification hypothesis that a person will generally experience the health-related benefits or 
costs of a given group membership only to the extent that they identify with that group (see 
Haslam et al., 2018). From these hypotheses, we predict that it is only when people identify 
with a given group that it has potential to impact on their health. Amongst other things, this 
means that the curative potential of groups is out of reach for those who experience loneliness 
— because their sense of social disconnection precludes them from accessing the range of 
psychological resources that flow from social group belonging.     
The above reasoning provides the basis for a novel approach to managing loneliness 
— one that is focused on efforts to build and sustain social identities and social identification. 
This is the purpose of the GROUPS 4 HEALTH (G4H) program — a structured and manualized 
intervention that seeks to translate insights from the SIAH into practice. G4H has previously 
been described in a published Phase I pilot study (Haslam et al., 2016; see also Chapter 15 in 
Haslam et al., 2018) and aims to build people’s social identity capital in the context of an in-
vivo group experience. The program raises awareness of the ways that group memberships 
influence health, whilst at the same time helping people to develop bespoke strategies to 
harness existing group ties as well as develop new ones to support connectedness (and 
thereby, health).  
The previously reported pilot study, conducted with 83 young adults experiencing 
social isolation and associated psychological distress, found that those who received the 
program reported reduced symptoms of depression, anxiety and loneliness relative to a group 
of 75 matched (but not randomly assigned) controls, with benefits sustained at six-month 
follow-up. As the social identity approach to health would predict, among those who took 
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part in G4H, these changes were also associated with an increased sense of connectedness to 
multiple groups. Yet while these findings were encouraging, greater rigour is clearly required 
to established G4H’s efficacy. This is the primary purpose of the present study, which 
evaluates G4H by means of a Phase II clinical trial. 
The present research 
There are numerous interventions to tackle loneliness and considerable variability in 
their effectiveness (Cacioppo et al., 2015; Masi et al., 2011). By targeting problems of social 
identification, G4H provides a unique theory-based strategy for addressing the lack of 
belonging and social disconnection central to loneliness (Haslam et al., 2018). To test this 
strategy, the primary objective of the present study was to examine the effectiveness of G4H 
relative to treatment-as-usual (TAU) in a sample of adults presenting with loneliness in 
association with clinically severe psychological distress or a diagnosed mental illness. 
Participants were randomly assigned to receive G4H or TAU. Those in receipt of 
other mental health treatments were not excluded from the study. While the mental health 
presentations in the sample were diverse in some cases they were severe, and so we could not 
ethically dissuade participants from seeking appropriate care elsewhere in addition to their 
participation in the trial. Our primary hypothesis (H1) was that perceived loneliness would be 
significantly reduced among G4H recipients, relative to those receiving TAU. This is because 
loneliness is the explicit focus of the G4H program, but is rarely the primary target of TAU, 
despite it sometimes being an element of TAU.   
Several secondary outcomes measures were also included with the aim of evaluating 
the efficacy of the G4H intervention more broadly. These included symptoms of social 
anxiety and depression, which are two mental health presentations commonly associated with 
loneliness (e.g., Lim, Rodebaugh, Zyphur, & Gleeson, 2016). Additionally, we included 
measures of multiple group membership, which had been found to be associated with change 
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in health outcomes in a pilot study of the intervention (Haslam et al., 2016), and self-reported 
General Practitioner (GP) visits, given evidence of the link between loneliness and frequent 
use of primary care services, including those offered by GPs (e.g., Cruwys, Wakefield, Sani, 
Dingle, & Jetten, 2018). Drawing on previous research, we predicted that while G4H and 
TAU would reduce depression symptoms (H2) and general practitioner visits (H3), G4H 
would be more effective in reducing social anxiety (H4) and increasing multiple group 
membership (H5). These latter predictions reflect the fact that the primary focus of G4H is on 
social factors known to be associated with loneliness — notably, processes involved in 
actively building and strengthening social group memberships (e.g., identifying groups that 
are a good fit, compatible, and likely to endure) — that contribute to the social anxiety seen 
in people who are lonely (Lim et al., 2016).   
Method 
Study design and power 
This study was registered with the Australian New Zealand Clinical Trials Registry 
(ACTRN12617001602314) and used an unblinded RCT design with participants assigned to 
G4H or to a control condition by computer software. The control condition, as reported in the 
trial registration, was intended as a wait-list. Participants on this wait-list were offered access 
to G4H after the completion of the follow-up timepoint. However, as over half the 
participants in this condition were in receipt of adjunct evidence-based mental health care 
(most commonly for depression), it was decided that TAU more accurately characterized this 
condition. Assessments were conducted at baseline and then at two month follow-up.  
Power analyses used the pre-post treatment group effect size for the primary outcome 
(loneliness) found in the Haslam et al. (2016) pilot study of G4H (d = 0.86)
1
. This suggested 
                                                 
1
 For comparative purposes, the mean effect sizes for loneliness interventions found in the 
Masi et al. (2011) meta-analysis were lower: d = -0.367 (range= −4.81 to 0.12) for single 
group pre-post designs, d=-0.459 (range= -1.88 to 0.11) for non-randomised group 
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that a minimum of 23 participants would need to be retained in each condition at follow-up 
for 80% power (Lehr, 1992). This figure was doubled to account for expected change in the 
TAU condition (n = 46), and increased further to 65 per condition to allow for attrition (based 
on an expected retention rate of 67% in the G4H pilot study; Haslam et al., 2016). This figure 
(n = 65 in the G4H condition) also functioned as a stopping criterion for recruitment to the 
intervention.   
Participants 
Participants were recruited from both the community as well as university health 
services through self and clinician referrals between April 2015 and February 2017. All were 
invited to complete a screening questionnaire if they were subjectively experiencing social 
isolation, and were eligible if either (a) diagnosed with a mental illness by a health 
professional or (b) reported symptoms that met the criteria for clinical depression (i.e., ≥ 5 on 
the Patient Health Questionnaire-9, PHQ-9). Despite the latter being lower than the Manea et 
al. (2012) criteria for diagnosis of major depressive disorder (i.e., a score falling between 8-
11 on the PHQ-9), in the present research we were interested in recruiting people with 
clinically impairing levels of depression, and this includes those with at least mild depression. 
No-one was excluded on the basis of comorbid conditions that are common in mental illness 
(e.g., anxiety, autism spectrum disorders), or in receipt of alternative treatment. Those 
presenting with moderate to severe mental illness symptoms were informed about, and 
encouraged to seek, adjunct treatment while completing the trial, if they were not doing so  
already. Assessment of eligibility was undertaken for 199 people. Of these, 79 people did not 
meet inclusion criteria, declined or were unable to participate, did not complete 
screening/baseline measures, or could not be contacted after completing screening and 
                                                                                                                                                       
comparisons, and d = -0.198 (range = -0.79 to 0.40) for randomised group comparisons. 
This is likely a reflection of the wide variation in the context of these interventions, many 
of which did not have a significant effect on outcomes. 
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baseline measures (see Figure 1). A range of reasons were provided by those who declined to 
participate (n = 24) and these included being unsure the program was for them, wanting to 
check with their psychologist/psychiatrist, wanting individual therapy, or finding the location 
of the clinic where the program was offered too far from home.   
Table 1 provides descriptive statistics for the final randomized sample at baseline 
(N=120). The mean age of participants was 31.06 years (SD = 12.80) and the majority in each 
condition were female (64%), Australian (69%), and Caucasian (74%). Among these 
participants, 59% had a formal mental health diagnosis, and 59% were receiving some form 
of adjunct mental health treatment (pharmacological and/or psychological)
2
.   
Intervention 
Groups 4 Health (G4H). This social identity theory-derived intervention focuses on 
the building and maintenance of positive social group identifications, as a theoretical agent of 
change in enhancing health and well-being. It targets specific social identity processes of 
multiple group membership, group identification, group maintenance, group gain, and group 
compatibility. All of these factors have been shown to protect health and well-being, 
particularly under conditions of challenge and vulnerability — whether this be due to illness, 
trauma, social disadvantage, diagnosis, or life change (Drury, Cocking & Reicher, 2009; 
Haslam et al., 2008; Iyer, Jetten, Tsivrikos, Postmes, & Haslam, 2009; Muldoon & Downes, 
2007; Walter, Jetten, Dingle, Parsell, & Johnstone, 2015). In doing so, the G4H program 
offers an in-vivo group experience where participants learn about tackling social 
disconnection with others who face similar challenges. By drawing on each other’s 
                                                 
2
 We do not report baseline differences between G4H and TAU in Table 1, given this is not 
recommended for RCT trials. Previous authors have argued that this is inappropriate 
because any such differences should be a chance occurrence (Pocock, McMurray & Collier, 
2015). In fact, the only difference that was found, after Bonferroni correction for use of 
multiple tests, was on the demographic variable education, (4) = 18.85, p = .001; with 
those allocated to G4H having a slightly lower level of education at baseline than those in 
TAU. In line with Pocock and colleagues’ argument that this is likely to be a chance result, 
no further analysis was conducted. 
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knowledge and resources, the group’s membership as a collective is as much a part of the 
intervention as the content of the program itself.    
The five-module program is manualized (Haslam et al., 2015a) and comes with an 
associated workbook (Haslam et al., 2015b) that supports participants through various 
program activities and exercises. G4H has been described in a number of previous 
publications (Haslam, 2018; Haslam et al., 2016, 2018), so here we only summarize its aims 
and content. Module 1, Schooling, is psychoeducational and aims to raise people’s awareness 
of the social groups in their lives and the role they play in health. In this, education is targeted 
not only at helping people harness those groups that enhance health, but also at increasing 
recognition of those group ties that can undermine and harm health. Module 2, Scoping, uses 
a Social Identity Mapping tool (Cruwys, Steffens, Haslam, Haslam, Jetten, & Dingle, 2016; 
Bentley et al., 2019) to help people create a visual illustration of their social group world. 
This is used as a basis for reflecting on the different groups in their life and how they relate to 
those groups. It also provides a basis from which to build and enhance group networks in the 
next two sessions. In Module 3, Sourcing, activities focus on maximising a person’s existing 
group relationships where they are positive, which involves brainstorming ways to reconnect 
with existing groups, recognizing and overcoming barriers to strengthening those bonds, and 
managing the give and take in relationships in order to help them endure. Module 4, 
Scaffolding uses the G4H group (which is a new group for all participants) as a platform from 
which participants can build on their existing relationships, where needed, to join new 
groups. As part of this module, people learn how to extend their group memberships in ways 
that are more likely to be compatible with their existing social identity network and they 
develop a social plan that they are encouraged to trial to achieve this. These first four sessions 
take place weekly, and each lasts between 60 to 90 minutes. The final module, Sustaining, 
takes place one month later to provide time and opportunities for people to trial their social 
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plans and focuses on them reporting back on their experiences of doing so. This fifth module 
is built upon both celebrating successes but also troubleshooting challenges, and also 
involves people revisiting their social identity map in order to reflect on ways this might have 
changed as a result of taking part in the program. 
In the present study, the program was administered in groups comprising between five 
and nine participants and facilitated by two provisionally registered psychologists completing 
supervised graduate training in the psychology clinic of the researchers’ university. 
Facilitators were trained in program delivery and received weekly group supervision, which, 
in addition to the use of a manualized program, contributed to treatment fidelity. This training 
included detailed discussion of the program background, content, and materials required for 
each session, as well as process issues involved in running a group program. Facilitators were 
asked to complete a checklist at the end of each session to determine compliance to the 
protocol. 
Measures 
These comprised scales to screen for psychological distress and mental health 
diagnosis prior to randomization, demographic information collected prior to study 
commencement, and primary and secondary outcome measures collected before, at 
completion and two months following G4H for those assigned to this intervention or during 
the same time period for those assigned to TAU.   
Demographics and screening. Participants were asked to indicate their gender, years 
of education, nationality, ethnicity, and current adjunct psychopharmacological and 
psychological treatment for mental health concerns (e.g., use of prescription medication, 
medical or psychological treatment). For the purposes of screening, participants were asked 
to complete the following measure of depression that differed from the outcome measure, and 
also to indicate if they had any mental health diagnoses.  
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Patient Health Questionnaire-9. (PHQ-9; Kroenke, Spitzer, & Williams, 2001). This 
comprised 9 items (e.g., feeling down, depressed, or hopeless), with participants asked to rate 
how frequently they had experienced symptoms in the last 2 weeks on a 4-point scale (0 = 
Not at all to 3 = Nearly every day; α = 0.85). The measure has excellent validity, with the test 
discriminating well between those with and without major depressive disorder (Kroenke et 
al., 2001). It also has good internal reliability ( = .86 and .89 in obstetric and primary care 
settings; Blackwell & McDermott, 2014) and test-retest reliability (r = 0.84 over 48 hours; 
Kroenke et al., 2001). At baseline, the mean PHQ-9 score of participants was 12.85 (SD = 
6.08); falling in the moderate depression range.  
Mental Health Diagnosis. Participants were asked if they had been diagnosed with a 
mental illness by a health professional, and if so, to indicate their diagnosis and the 
profession of the person who provided the diagnosis (e.g., GP, psychiatrist).  
Primary outcome. 
Loneliness. This was assessed using the Roberts UCLA Loneliness Scale (RULS-8) 
which has good construct validity, sound internal consistency ( = .78 in adolescents), and 
moderate test-re-test reliability (r=0.48 in non-clinical samples) (Goosens, Klimstra, Luyckx, 
Vanhalst, & Teppers, 2014; Roberts, Lewinsohn, & Seeley, 1993). The eight items in this 
scale (e.g., How often do you feel…. : isolated from others? part of a group of friends?) were 
rated on a 4-point scale (α=0.70 for the present study; 1 = Never, 4 = Always). Items were 
summed to yield a scale with scores ranging from 8-32, with higher values indicating greater 
perceived loneliness.  
Secondary outcomes.  
 Depression. Participants completed the seven-item depression subscale of the 
Depression, Anxiety, and Stress Scale-21 (DASS-21; Lovibond & Lovibond, 1995). The 
depression subscale has excellent internal consistency (e.g.,  = .94) and concurrent validity 
GROUPS 4 HEALTH 
 
14 
(correlating positively and highly with other measures of depression e.g., the Beck 
Depression Inventory) in clinical samples (Antony, Bieling, Cox, Enns, & Swinson, 1998; 
Crawford & Henry, 2003). Participants rated how frequently in the preceding week they had 
experienced depression symptoms (e.g., I felt down-hearted and blue) on a 4-point scale (0 = 
Did not apply to me at all, to 3 = Applied to me very much, or most of the time; α = 0.90). In 
line with recommendations for scoring, responses were summed and multiplied by two. At 
baseline, mean scores were in the “extremely severe” clinical range (M = 20.32, SD = 9.69). 
While this differs from the PHQ-9 at screening, this could be explained by the DASS-21 
being recorded subsequently in which presentation of symptoms were targeted in the 
previous week (as opposed to two weeks). 
General Practitioner (GP) visits. This was measured with a single item: “How many 
times have you been to see a general practitioner (medical doctor) in the last month” (as used 
in Vedsted & Christensen, 2005). At baseline, participants reported seeing a GP on average 
1.12 times in the last month (SD = 1.41, range = 0-6).  
Social anxiety. This was assessed with the short version of the Social Phobia 
Inventory (mini-SPIN; Connor, Kobak, Churchill, Katzelnick, & Davidson, 2001), 
comprising three items (e.g., “Being embarrassed or looking stupid are among my worst 
fears”; α = 0.83). The mini-SPIN discriminates well between those with and without social 
anxiety disorder, and has strong internal consistency (α = .90) and test-retest reliability (r = 
.82; Fogliati et al., 2016). Each item is rated on a 5-point scale (1 = not at all, 5 = extremely), 
with higher scores indicating greater social anxiety.  
Multiple group memberships. People’s sense of belonging to multiple groups was 
assessed using a standard 4-item multiple group membership scale (Haslam et al., 2008; e.g., 
“I have strong ties with lots of different groups”) which has good internal consistency (α = 
.78 - .93, see Haslam et al., 2018), but no reported test-retest reliability. Each item was rated 
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on a 5-point scale (1 = do not agree at all, 5 = agree completely; α = 0.87) with higher scores 
indicating stronger connectedness with multiple groups. The baseline mean of 1.79 (SD = 
0.85) in this sample was lower than that reported in other vulnerable populations (e.g., 
homelessness; Jetten et al., 2015).  
Program adherence. At the end of each session, facilitators were asked to rate the 
extent to which they covered key issues and activities in each session. The number of 
elements ranged between 6 to 10 across sessions, with some repeated items (e.g., establishing 
session goals, reviewing homework/reflection) and others unique to specific sessions (e.g., 
positive features of social identity maps, development of social plans). Ratings for each item 
ranged from 1 to 7 (1 = not done, 7 = extensively covered). To reduce the likelihood of 
facilitators giving socially desirable responses, these ratings were completed anonymously 
and facilitators were encouraged to be honest in their responses and told that their feedback 
was being used to assess the program content.   
Procedure 
Ethical approval for the study was granted by the researchers’ university. Recruitment 
notices were distributed via letters and flyers to community and university service providers 
(e.g. General Practitioners, psychologists, counsellors, psychology interns, and other health 
professionals) and their clinics. These notices offered free participation in a 5 X 1.5-hour 
group program suitable for people experiencing social isolation and disconnection. 
Participants were randomized to receive either G4H or TAU by one research assistant using a 
computer-generated random number sequence. Allocated numbers were not held equal 
between conditions, but were fully random, resulting in slightly more participants being 
allocated to G4H. The TAU participants were offered the G4H intervention after completing 
the follow-up measures.  
As shown in the CONSORT diagram (see Figure 1), 199 participants were assessed 
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for eligibility and 141 completed the screening measures to determine eligibility. Those 
eligible, once condition allocation had been made, were contacted by the research assistant 
team, and were informed about the timeframe to receive the intervention — either less than 2 
weeks for those in the G4H condition, or a minimum of four months for those wishing to 
receive the intervention but allocated to TAU.  
G4H was delivered in the Psychology Clinic of the researchers’ university. The first 
group commenced in May 2015 and the final group in February 2017, after the projected 
number of participants (N = 65) had been allocated to the intervention. Participants 
completed baseline measures at the time of allocation, and follow-up measures were taken 
approximately four months after baseline. All data collection was completed in June 2017. 
For participants receiving G4H, the intervention occurred over a period of eight weeks, and 
the follow-up measures were completed about two months after the program ended. Our 
priority was to collect follow-up data from all participants who consented, and so flexibility 
in the timing was allowed to include participants who were travelling, moving overseas, or 
completing university exams. As a result, the follow-up period ranged between 55 days to 
204 days and most participants completed these measures online. The average time between 
baseline and follow-up was 119 days (SD = 29.46) in TAU and 128 days (SD = 31.16) in 
G4H, with no significant difference between conditions, t(76) = -1.35, p = .182.  
An additional timepoint was available for 56 participants, taken immediately 
following completion of the program in the G4H condition (n = 37; M = 77 days from 
baseline; SD = 15.30) and immediately prior to commencing G4H for those in the TAU 
condition who took up the option of receiving G4H after a waitlist period (n = 19; M = 183 
days from baseline; SD = 20.45). These supplementary data were included in follow-up 
analyses reported below that replaced the time predictor with an indicator of days since 
baseline and include all available measurements.  
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Analysis strategy  
Mixed-effects repeated-measures analyses were conducted to test the primary 
hypotheses (Donohue & Ainsen, 2012; Mallinckrodt, Clark & David, 2001; Molenberghs et 
al., 2004). This approach honours the intention-to-treat principle by including (i) baseline 
data for all randomized participants (N = 120), (ii) follow-up data for those allocated to G4H 
who did not complete the intervention, and (iii) those in both conditions who did not have 
follow-up data (n = 38). The mixed-effects model included time, condition and their 
interaction as fixed effects, with participant and group as random effects. Data were analysed 
in R using the lmer and emmeans packages (Bates et al., 2014; Lenth, et al., 2019).  
A number of follow-up analyses were also conducted. First, we conducted a mixed-
effects analysis that excluded participants whose adjunct treatment status changed (n = 15) 
and investigated the moderating effect of adjunct treatment, focusing on pharmacological 
treatment which was slightly higher in the G4H group at baseline. Second, a multivariate 
analysis of covariance (MANCOVA) was conducted that assessed the five outcome measures 
in the same model, with baseline measures of each variable included as covariates. A final 
mixed-effects analysis that replaced the predictor of time with the continuous predictor days 
since baseline was also conducted. This analysis allowed all available data to be included in 
the analysis (up to three timepoints per participant). Within-subjects effect sizes were 
calculated as recommended by Masi and colleagues (2011), with the pre-post difference in 
each condition divided by the pooled standard deviation. Clinically significant change was 
calculated as the proportion of participants in each condition who experienced reliable 
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As indicated in Figure 1, of the 120 participants allocated to a condition, 36% of G4H 
participants were lost to follow-up; more than a third of these were lost due to the protocol 
requirement of attending a minimum of 3/5 sessions. This largely accounts for the difference 
in attrition between this condition and TAU, which was 24%.  
The mean adherence ratings on session content (from 1-7) were 5.4 Session 1 (SD=0.58), 
5.1Session 2 (SD=1.08), 5.3 Session 3 (SD=0.89), 5.2 Session 4 (SD=1.22), and 5.9 Session 5 (SD=0.67). 
These indicate that facilitators were typically able to engage in “considerable discussion” of 
the key elements of each session,  thereby providing evidence of good adherence to program 
content.     
Primary analysis  
The primary findings are summarized in Table 2. Figures 2 to 6 show the estimated 
marginal means and SEs from the output of these analyses.  
Loneliness. Both the main effect of time,   = -.35, p  < .028, and the time X 
condition interaction were significant,   = -.74, p < .001. The interaction is shown in Figure 
2, with further analysis indicating that loneliness decreased significantly in G4H, t(97.0) = 
7.27, p < .001, but not in TAU, t(90.8) = 2.23, p = .098. This decline was an average of 3.83 
points (SE = 0.53, d = -1.16) in G4H vs. 1.23 points (SE = 0.55, d = -0.36) in TAU. Reliable 
improvement was observed in 35.7% of the G4H group and 12.5% of the TAU group.  
Depression. The main effect of time was significant,  = .39, p  = .009, but the time X 
condition interaction was not,  = -.33, p = .108 (see Figure 3). Depression symptoms 
decreased significantly in the G4H condition, t(96.8) = -5.10, p < .001, and also in the TAU 
condition, t(91.7) = -2.65, p = .035. This corresponded to an average decrease of 7.29 points 
in the G4H condition (SE = 1.43; d = -0.67) and an average of 3.94 points in the TAU 
condition (SE = 1.49, d = -0.35). Reliable improvement was observed in 45.2% of the G4H 
group and 25% of the TAU group.  
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GP visits. As illustrated in Figure 4, The main effect of time was not significant,  = 
.36, p = .053, but the time X condition interaction was,  = -.75, p = .004. This interaction 
reflected a non-significant decrease in GP visits in the G4H condition, t(98.8) = -2.23, p = 
.098, and a non-significant increase in GP visits in the TAU condition, t(91.3) = 1.96, p = 
.172, GP visits decreased an average by 0.53 visits per month in the G4H condition (SE = 
0.24, d =-0.21), and increased by an average of 0.49 visits per month in the TAU condition 
(SE = 0.25, d = 0.42). A reliable reduction was observed in 19% of the G4H group and 5% of 
the TAU group. 
Social anxiety. The main effect of time was non-significant,  = .03, p  = .803, but 
the time X condition interaction was,  = -.53, p = .003. This effect is shown in Figure 5, with 
further analysis indicating that social anxiety decreased significantly for those in receipt of 
G4H, t(85.9) = -4.22, p < .001, but not in the TAU condition, t(83) = .25, p = .993. This 
corresponded to an average decrease of 0.50 points in the G4H condition (SE = .12, d = -
0.53) and a non-significant increase of 0.03 points in the TAU condition (SE = .12, d = .03). 
Reliable improvement was observed in 21.4% of the G4H group and 5% of the TAU group.  
Multiple group memberships. Both the main effect of time,  = .37, p < .010, and 
the time X condition interaction were significant,  = .52, p = .009 (see Figure 6). Further 
analysis showed that group memberships increased significantly in G4H, t(95.8) = 6.57, p <. 
001, and also increased significantly in TAU, t(91.1) = 2.64, p = .036. This corresponded to  
an average increase of 0.56 points in the G4H condition (SE = .14, d = 0.96), and of 0.32 
points in the TAU condition (SE = .14, d = 0.44). Reliable improvement was observed in 
47.6% of the G4H group and 32.5% of the TAU group.  
Follow-up analyses  
Stability of adjunct treatment. Almost 60% of participants were in receipt of some 
form of adjunct treatment (psychopharmacological or psychological) at baseline, with no 
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significant differences between conditions, t(116) = .92, p = .362. Overall, only 13% of 
participants (15 people) reported some change in adjunct treatment across the course of the 
trial, with the remaining 87% indicating no change in their receipt (or not) of adjunct 
treatment for mental health concerns. Of these 15, five ceased adjunct treatment (two in the 
G4H condition) and 10 commenced adjunct treatment (six in the G4H condition). There was 
no significant difference between conditions in the likelihood of changing adjunct treatment 
status, t(118) = -.43, p = .669. 
Adjunct psychopharmacological treatment. Although participants were randomly 
allocated to condition, there was a slightly higher proportion of participants in the G4H 
condition who were in receipt of psychopharmacological treatment at baseline. The 
difference between G4H and TAU in use of such treatment at baseline was significant 
without Bonferroni correction for multiple comparisons, t(118) = 2.24, p = .026, d = .43, but 
non-significant when such correction was applied (revised significance criterion of p < .004). 
Furthermore, as described above, 15 participants reported some change in their adjunct 
treatment status over the course of the trial.  
To investigate this further, a post-hoc mixed-effects analysis was conducted, in which 
these 15 participants were excluded and psychopharmacological treatment status was added 
as a moderator (0 = No; 1 = Yes). These analyses revealed only two significant effects of 
adjunct treatment status. First, there was a main effect of treatment status on loneliness, with 
those in receipt of psychopharmacology reporting higher levels of loneliness across 
timepoints,  = .60, p = .039. Second, there was a three-way interaction between treatment 
status, time, and condition on depression (p = .024, see Figure 7). This indicated that 
participants in receipt of psychopharmacology tended to have more severe depression 
symptoms at baseline and to show moderate improvement in depression symptoms over time, 
regardless of whether they were in the TAU or G4H condition, t(132.97)=0.63, p=.997. 
GROUPS 4 HEALTH 
 
21 
However, participants not in receipt of psychopharmacology tended to have lower depression 
scores at baseline (albeit still in the ‘moderate’ clinical range), and those in the G4H 
condition showed greater improvement than those in the TAU condition, t(79.31) = 4.83, p 
<.001.  
Multivariate analysis of covariance (MANCOVA). A more traditional approach to 
analysing clinical trial data uses MANCOVA, an analysis which allows for examination of 
interrelationships among all outcome variables; five in this case. In order to mirror our 
mixed-effects intention-to-treat analyses as closely as possible, we specified a MANCOVA 
model that included the five outcome measures at follow-up as dependent variables, with 
baseline measures of each included as covariates. Condition was the between-subjects 
independent variable. Multiple imputation was used to handle missing data at follow-up, with 
five imputations conducted using the monotone method in SPSS v.25, estimated using the 
five outcome variables at both timepoints as well as treatment condition, adjunct treatment 
status, and the number of days from baseline to follow-up (Havati Rezvan, Lee, & Simpson, 
2015). The results of this analysis are reported in Table 3. Overall, the findings were similar 
to those of the mixed-effects model, with G4H leading to significant reductions in loneliness 
and social anxiety relative to TAU. G4H also predicted a significant increase in multiple 
group memberships relative to TAU. However, the results for depression and GP visits were 
not significant.  
Number of days from baseline to follow-up. Finally, a follow-up analysis was 
conducted in which the predictor variable of timepoint (0=baseline; 1 = follow-up) was 
replaced in the model with a continuous measure of the number of days since baseline. This 
allowed all the available data to be analysed for those participants who completed additional 
measures (typically between baseline and follow-up in the G4H condition, and after follow-
up in the TAU condition). The results of this analysis are presented in Table 4. To 
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summarize, the focal effects (i.e., interaction of “days since baseline” and condition) were 
significant, and had the same pattern of means, for loneliness, social anxiety, GP visits, and 
multiple group memberships as in the primary analysis.  
Discussion 
 This RCT examined the efficacy of a novel group intervention targeting social group 
connectedness, GROUPS 4 HEALTH (G4H), relative to treatment-as-usual (TAU). Confirming 
the efficacy of G4H, findings from our analysis largely supported predictions. Specifically, 
there was evidence that compared to TAU, G4H was associated with a greater reduction in 
symptoms of loneliness (H1) and social anxiety (H4). Evidence of a significant interaction in 
GP service use provided partial support for H3, and showed that G4H was better than TAU in 
reducing visits. Also as predicted, we found evidence of a decline in depressive symptoms in 
both conditions (supporting H2), indicating that G4H and TAU were equally effective on this 
outcome. Post-hoc follow-up analyses exploring the contribution of adjunct 
psychopharmacological treatment showed that G4H was significantly better than TAU in 
reducing depression among those who were not taking medication. Finally, partial support 
was found for H5 in which we predicted that increased strength of belonging would be 
specific to G4H. Here we found evidence of a significant increase in multiple group 
membership in both G4H and TAU.  
As this summary indicates, the present results provide full support for predictions  
regarding the efficacy of G4H over TAU in reducing perceived loneliness. These findings 
extend those reported in a previous pilot study (Haslam et al., 2016), and further demonstrate 
the value of targeting positive group identification as a strategy for reducing loneliness. The 
moderate-to-large effect sizes associated with G4H in the present study also compare 
favourably with those from Masi et al.’s (2011) meta-analysis which found a small overall 
effect size for randomized group comparison studies (i.e., d = 0.198), but a moderate effect 
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size of d = 0.598 for social-cognitive interventions within this category of study design. 
Moreover, the G4H program also had a significant effect in reducing social anxiety, which 
previous research has shown to be not only co-morbid with loneliness (Teo, Lerrigo, & 
Rogers, 2013), but also to predict the development of loneliness better than depression (Lim 
et al., 2016). Indeed, based on the latter findings, Lim and colleagues (2016) conclude that 
failure to manage symptoms of social anxiety alongside loneliness is likely to result in 
suboptimal outcomes. As G4H had a positive effect on both these symptoms, it offers a 
substantive advance on existing approaches.  
Our follow-up analyses, albeit post-hoc, revealed a main effect of adjunct 
psychopharmacological treatment on loneliness and a three-way interaction between time, 
condition, and medication use on depression. The former indicated that those in receipt of any 
form of adjunct psychopharmacological treatment reported greater perceived loneliness, and 
this was evident in both G4H and TAU. This, in and of itself, is not surprising as social 
disconnection and associated loneliness is common in a range of health conditions and 
contexts (Haslam et al., 2018). What was more interesting, in terms of potentially 
differentiating the effects of G4H and TAU, was the three-way interaction on depression. This 
indicated that among those not in receipt of psychopharmacology, G4H produced a greater 
reduction in depression symptoms than TAU. These participants tended to have more 
moderate symptoms and received greater benefit from G4H in management of depression 
than those in TAU. For those people in receipt of psychopharmacology, symptoms were more 
severe at baseline (which presumably is why they were prescribed medication), and moderate 
improvement was observed across conditions making it difficult to tease apart the effects of 
G4H and TAU.      
The evidence in relation to multiple group membership was more mixed, with 
improvement in both conditions; not just in G4H as predicted. Although it is unlikely that 
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TAU targets multiple group membership as directly as G4H, it nevertheless treats depression, 
and, to the extent that reduced group membership is symptomatic of depression (as argued in 
Cruwys et al., 2014), the improvement associated with TAU on this outcome should not be 
that surprising. Nevertheless, effect sizes also indicated that the magnitude of the treatment 
effect associated with G4H was greater than that for TAU (d = 0.96, d = 0.44, respectively), 
which suggests that the former should be the treatment of choice where multiple group 
belonging is the target of intervention. The evidence was also more mixed for GP visits, 
where the predicted decline was not found in either condition. However, a significant 
interaction indicated that the trajectories of change differed between conditions, with visits 
tending to decline among those who received the G4H program, and tending to increase for 
those receiving TAU. This suggests that participants may have been less likely to utilize 
health services if their needs were met by the G4H program. This can only be speculation at 
present, given that GP service use was numerically (but not significantly) higher at baseline 
for G4H than TAU recipients. Accordingly, there is clearly a need for future research to 
identify the nature of GP visits (for adjunct treatment monitoring or other reasons) in addition 
to their number, and to extend the evaluation timeframe to gain a better picture of primary 
care use.  
Effect sizes provide one indication of the clinical significance of treatment effects, 
and, on this indicator, we found that the magnitude of the effect associated with G4H was 
consistently greater than TAU (with effect sizes ranging from 0.21 to 1.16 and from 0.03 to 
0.44, respectively). Beyond this though, we calculated the RCI for all outcomes and here too, 
we found that evidence of reliable improvement was greater in response to G4H (with 
reliable change for 21.4% to 47.6% of G4H vs. 5.0% to 32.5% of TAU participants). Added 
to evidence of statistical change, these indices provide further support for G4H’s capacity to 
make a meaningful improvement in the lives of people who are experiencing loneliness.    
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There are also theoretical implications of our findings. The social identity approach,  
unlike most others applied to health, stresses the value of working with social groups that are 
already, or have the capacity to become, a part of people’s lives, and in so doing, draws 
effectively on the resources they can provide to protect health. This suggests that social 
identity management of the form that G4H promotes can be helpful not only in overcoming 
loneliness, as demonstrated here, but also in managing the social disconnection that is 
common in a range of health conditions and contexts.  
Limitations and future research 
As in many clinical trials, the present study has its limitations, and several are 
particularly noteworthy. First, receipt of adjunct treatment was not an exclusion criterion, 
largely for ethical reasons, and the fact that diverse interventions were offered in TAU was 
not ideal. While this contributed to the study having an active control, it raises questions 
about the extent to which the G4H program was exclusively responsible for observed 
outcomes. Over half the participants were in receipt of evidence-based treatment of a diverse 
nature; most commonly antidepressant medication or psychological therapy targeting 
depression. Our analysis of these data was not a priori and thus, would benefit from 
replication. In particular, future studies might use a single adjunct treatment as a control and 
ensure no adjunct treatment for those in receipt of G4H to differentiate treatment effects more 
clearly, particularly among those with more severe symptomatology. Alongside medication, 
the most obvious would be cognitive behaviour therapy, as this has the strongest evidence-
base of psychological therapies to date, and elsewhere its principles have been found to be an 
effective component of loneliness interventions (Masi et al., 2011). An RCT comparing G4H 
and CBT for depression is currently underway. In this trial we expect that CBT and G4H will 
be equally effective in reducing symptoms of depression (as in the present study), but that 
G4H may be more effective in reducing loneliness and associated social anxiety, which is a 
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key predictor of longer term loneliness (Lim et al., 2016).  
Second, while the present paper focused on the effect that G4H had on outcomes, 
questions remain about mechanisms. Notably, having found that G4H was better than TAU in 
reducing loneliness and improving depression when G4H was the sole form of treatment (i.e., 
in the absence of adjunct treatment) how is it that it achieves these outcomes? Theoretically, 
the social identity approach predicts that one mechanism through which this may occur is the 
building and strengthening of people’s sense of belonging to multiple social groups; 
something that is explicitly targeted in the G4H program. In line with this reasoning, our 
published pilot data show that G4H was associated with increased strength of belonging to 
multiple groups both on program completion and six months later (Haslam et al., 2016). As 
the present study did not test mechanism, we are not in a position to conclude whether 
multiple group membership was an agent of change. We are also not in a position to state 
whether other possible mechanisms were involved — whether derived from the social 
identity approach to health (in which mechanisms such as self-esteem and perceived control 
are theorized to enhance outcomes; see Haslam et al., 2018) or cognitive behaviour theory (in 
which improvement is theorized to occur through the modification of maladaptive 
cognitions). This would require measurement of these mechanisms over time to capture 
change processes; something that was not done in this study. Additionally, to be confident 
about the basis for therapeutic change, there are numerous requirements in addition to 
showing strong association, including demonstration of the specificity of the mechanism, 
replicability and dose-response relationships over time (Kazdin, 2007). Accordingly, there is 
a need for future research to invest in such demonstrations, in order to provide a more precise 
understanding of the ways in which G4H improves outcomes. 
A third factor that warrants attention in future research is program integrity. While the 
present study captured facilitator responses to program content and consistency, there is 
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clearly much more that can be done to assess this rigorously. In particular, future studies 
could audio- and video-tape sessions (with participant permission) to assess therapist 
competence (not just adherence), as well as the extent to which therapists included activities 
and approaches that were specific to G4H (vs. similar to those used in psychological TAU). 
It will also be important to collect data from participants themselves concerning their 
perceptions of program integrity and expectations of treatment outcome as these can be 
associated with treatment adherence and thus influence treatment outcomes (e.g., Uebelacker, 
Weinstock, Battle, Abrantes, & Miller, 2018). 
Finally, there are measurement limitations, related to the brevity of some scales used 
(notably, the RULS and mini-SPIN), the failure to include objective diagnosis, and to the fact 
that the additional data included in the supplementary days since baseline analysis was 
collected at different timepoints across conditions. As a consequence, the missing data from 
the latter were not missing at random, which limits the conclusions that can be drawn from 
this particular analysis. Missing data at follow-up were handled using a full information 
likelihood method for the primary analysis, and using multiple imputation in the MANCOVA 
analysis. Although these strategies went some way towards addressing the bias associated 
with participants lost to follow-up (Larsen, 2011; Jacobsen, J.C., Gluud, C., Wetterslev, J., & 
Winkel, P, 2017), future trials should prioritise retention. These are recognized challenges in 
any clinical trial, yet attention to these issues is necessary to gain the comprehensive 
understanding of treatment effectiveness required for psychological intervention.     
Conclusion 
“All the lonely people, where do they all belong?” 
Eleanor Rigby, Lennon-McCartney  
This Beatles song’s poignant riff on the solitary lives of Eleanor Rigby and Father 
McKenzie speaks to a core question at the heart of loneliness: where and how might people 
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who are socially and psychologically isolated be helped to feel a sense of belonging? G4H 
provides a novel answer to this question through a focus on building people’s sense of 
connection with social groups that they perceive to be meaningful and self-relevant, and in 
ways that serve to build a sense of shared social identity with others. Speaking to the efficacy 
of this solution, findings of the trial we have presented here provide evidence of G4H’s 
capacity to reduce loneliness, and thereby lessen its damaging mental health consequences.   
More work is clearly needed to strengthen this case, notably in the form of research 
that compares the efficacy of G4H to cognitive behavioural approaches, and large-scale 
multicentre studies. It would appear that much is to be gained by following this path, not least 
in helping determine the distinctive contributions that social identification, cognitive biases, 
and their theoretical underpinnings make to understanding and managing the health and 
social costs of loneliness. Beyond this too, there are additional benefits of G4H related to the 
ease with which it can be facilitated, its non-pharmacological nature, its capacity to build 
connectedness to community, and its transdiagnostic potential. As these benefits and the 
present findings suggest, G4H has the capacity to be a useful tool in the arsenal of those 
seeking practical ways of addressing this pressing social issue.    
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Table 1  
Descriptive statistics at baseline in each condition  
 
 Treatment as Usual (TAU) 
Condition N = 54 
Groups 4 Health (G4H) Condition 
N = 66 




Education 0% Year 10 or less 
35.2% High school certificate 
3.7% Certificate or diploma 
50.0% Bachelor degree 
11.1% Postgraduate degree 
4.5% Year 10 or less 
34.8% High school certificate 
21.2% Certificate or diploma 
19.7% Bachelor degree 
19.7% Postgraduate degree 
Nationality 69.2% Australia 
9.6% China 




6.3% Dual including Aus 
21.9% others 








 38.3% None 
42.6% Major Depression 
35.2% Anxiety Disorder (GAD, 




40.9% Major Depression 
39.4% Anxiety Disorder (GAD, 















 M SD Range M SD Range 
Age 30.00 11.64 18-69 31.91 13.69 17-68 
Primary outcome:       
Loneliness 25.00 2.78 16-31 25.13 3.11 10-30 
Secondary outcomes:        
Depression 19.70 9.40 0-40 20.82 9.96 2-40 
Social anxiety 3.53 1.05 1.00-5.00 3.39 1.11 1.00-5.00 
General Practitioner visits 0.78 0.97 0-4 1.41 1.65 0-6 
Multiple group memberships 1.84 0.84 1.00-3.75 1.75 0.86 1.00-4.00 
 
Note. N = 120.  
a. Note that many participants had multiple diagnoses and so these percentages do not sum to 100%. 
SAD = Social anxiety disorder; GAD = Generalized Anxiety Disorder; PTSD = Post traumatic 
stress disorder.  
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Table 2  






Note. This table presents the outcome of three-level mixed effects models in which Level 1 
(time) was a fixed effect, Level 2 (participant) was a random intercept and Level 3 (therapy 
group) was a random intercept. TAU participants were categorized as being in the same 
group for the purposes of this analysis. The full sample (N=120) was used, to honor the 
Intention-to-Treat Principle.  
  









(Level 3 - 
Group) 
Loneliness     .253 .054 
Time -.350 .157 90.76 .028*   
Condition .140 .189 40.75 .459   
Time * Condition -.743 .218 93.58 <.001*   
 
Depression 




Time -.393 .148 91.67 .009*   
Condition .061 .204 54.46 .762   
Time * Condition -.334 .206 93.98 .108   
 
Social anxiety 




Time .030 .151 83.03 .803   
Condition -.164 .198 36.33 .413   
Time * Condition -.525 .169 84.34 .003*   
 
General Practitioner visits 




Time .362 .184 91.34 .053   
Condition .432 .207 70.35 .041*   
Time * Condition -.752 .255 94.75 .004*   
 
Multiple group membership 




Time .375 .142 91.12 .010*   
Condition -.090 .195 47.41 .647   
Time * Condition .523 .197 93.25 .009*   




Table 3  
Multivariate analysis of covariance  
 
 
Note. N = 119. Baseline measures of all five outcome variables were included as covariates, 
and missing data at follow-up was imputed using multiple imputation, with pooled estimates 
reported here. The omnibus effect of condition was significant, F(5,108)=8.04, p < .001. A 
per-protocol MANCOVA that analysed only completers(N=82) found comparable results 
with significant omnibus and condition effects for loneliness, social anxiety, and multiple 





 F (1,113) p Partial 2 Estimated marginal means at follow-up 
 G4H TAU 
 M SE M SE 
Loneliness 23.68 <.001* .18 20.40 .42 23.51 .47 
Depression   1.40   .238 .01 17.66 1.19 19.80 .1.33 
Social anxiety 20.36 <.001* .15 3.02 .08 3.57 .09 
General Practitioner visits   .101   .752 .00 2.19 .27 2.32 .31 
Multiple group 
memberships 
  10.07   .002* .08 2.65 .10 2.17 .11 
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Table 4  
Mixed effects model with a continuous measure of timepoint (days since baseline)  
  









(Level 3 - 
Group) 
Loneliness     .298 .075 
Days Since Baseline -.31 .074 148.77 <.001   
Condition -.276 .179 34.50 .132   
Days Since Baseline * Condition -.339 .112 151.35 .003*   
 
Depression 
    .397 .061 
Days Since Baseline -.268 .072 140.81 <.001*   
Condition .171 .183 36.09 .355   
Days Since Baseline * Condition -.169 .109 143.05 .125   
 
Social anxiety 
    .611 .006 
Days Since Baseline -.046 .067 129.43 .494   
Condition -.415 .174 25.82 .025*   
Days Since Baseline * Condition -.214 .102 130.80 .037*   
 
General Practitioner visits 
    .157 .058 
Days Since Baseline .072 .092 156.89 .434   
Condition .103 .173 38.07 .555   
Days Since Baseline * Condition -.319 .138 158.63 .022*   
 
Multiple group membership 
    .374 .058 
Days Since Baseline .316 .072 145.71 <.001*   
Condition .274 .179 37.00 .133   
Days Since Baseline * Condition .250 .108 148.00 .022*   
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Excluded (n = 20) 
- Did not meet inclusion criteria (n = 5) 
- Declined to participate (n = 1) 
- Not available to attend sessions (n = 4) 





Excluded (n = 58) 
- Declined to participate (n = 24) 
- Did not complete screening/baseline 
measures (n = 29) 
- Other reasons (n = 5) 
 
 
Allocated to Active Condition (G4H) 




Excluded (n = 1) 
- Incomplete baseline data (n = 1) 
 
 
Follow-up (n = 46) 
- Completed follow-up at four months (n = 42) 
- Did not complete follow-up (n = 4) 
Reasons: Other – could not contact (n = 4) 
 
Baseline (n = 54) 
- Received allocated TAU (n = 53) 






Completed screening measures  
(n = 141)  
 
Allocated to conditions             
(n = 121)  
 
Assessed for eligibility  
(n = 199) 
 
Follow-up (n = 53) 
- Completed follow-up at four months (n = 40) 
- Did not complete post control (n = 13)  




Baseline (n = 66) 
- Received allocated intervention (n = 46) 
- Did not attend initial session (n = 10) 
- Completed less than 3 sessions of G4H (n = 9):  
Reasons: Withdrew from study (n = 4) 
                Study commitments (n = 2) 
                Pregnancy (n =1) 




Figure 1. RCT CONSORT diagram 
 
Allocated to Treatment as Usual (TAU) 
















Figure 2. Intention to treat analysis on loneliness.  
















Treatment as usual Groups 4 Health






Figure 3. Intention to treat analysis on depression.  
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Figure 4. Intention to treat analysis on health service utilisation.  
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Figure 5. Intention to treat analysis on social anxiety.  
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Figure 6. Intention to treat analysis on multiple group memberships.  
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Figure 7. Three-way interaction between time, condition, and adjunct pharmacological 
treatment predicts depression.  
 
Note. Error bars represent standard errors. N = 105; 15 people whose adjunct treatment status 
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